Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 6/20 | 0.48 |
| ▸ | CNR1 | P21554 | 11/20 | 0.47 |
| ▸ | CNR2 | P34972 | 11/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15557238 | 0.86 | HTR3A (0.59) | HTR3ACNR1CNR2KDM4EPDE4A | |
| SCHEMBL8692020 | 0.84 | CNR1 (0.50) | CNR1CNR2KDM4EATM | |
| SCHEMBL28146834 | 0.80 | KDM4E (0.48) | HTR3ACNR1CNR2KDM4EATM | |
| SCHEMBL15897857 | 0.80 | CNR1 (0.48) | HTR3ACNR1CNR2KDM4EATM | |
| SCHEMBL9171932 | 0.80 | CNR2 (0.64) | CNR1CNR2KDM4E | |
| SCHEMBL26109913 | 0.79 | KDM4E (0.40) | KDM4EPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2050633 | 0.78 | CNR1 (0.69) | CNR1CNR2KDM4E | |
| SCHEMBL28072744 | 0.78 | CNR2 (0.69) | CNR1CNR2 | |
| SCHEMBL17176262 | 0.78 | HTR3A (0.62) | HTR3ACNR1CNR2ATM | |
| SCHEMBL17170619 | 0.77 | HTR3A (0.59) | HTR3ACNR1CNR2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3252049-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-12-06 | — | — | EP | disclosed |
| EP-3252050-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-12-06 | — | — | EP | disclosed |